Unlocking the genetics of skin cancer

2024-11-12T11:17:26+00:0012 November 2024|

Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.

Personalising cancer treatment using the gut microbiome

2024-09-06T10:23:10+01:006 September 2024|

Did you know that your gut bugs may affect your cancer risk? Dr Ashray Gunjur, Clinical Research Training Fellow at the Wellcome Sanger Institute, is exploring how clinicians can use the biology of the gut microbiome to personalise cancer treatment.

Targeting skin cancers

2014-11-26T10:46:52+00:0026 November 2014|

26.11.14 Many melanomas don’t respond to existing drugs and most eventually become resistant to treatment. Marco Ranzani explains how researchers are searching for new therapies